The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Vicks Vaposteam Lavender
Camphor, (-)- · CAMPHOR, (-)- .062 g/mL · Inhalant · Respiratory (Inhalation) · Kaz USA, Inc
NDC 69901-0523-08 · 1 BOTTLE, PLASTIC in 1 BOX / 236 mL in 1 BOTTLE, PLASTIC · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for camphor (other) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- M012
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Camphor, (-)- (Inhalant)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Kaz USA, Inc | CAMPHOR, (-)- .062 g/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Vicks Vaposteam Lavender — NDC 69901-0523-08," retrieved September 3, 2026, https://drugdashboards.com/drug/69901052308.
Free to cite with attribution — see how the data is put together.